Abstract
In this issue of JVIR, Tsauo et al (1) report the outcomes of a single-arm retrospective study of 126 cirrhotic patients with hepatocellular carcinoma (HCC) who underwent transjugular intrahepatic portosystemic shunt (TIPS) creation for the secondary prevention of gastric variceal (GV) bleeding (1). Major results included technical success in 124 (98.4%) cases; shunt traversal of tumor in 8 (6.3%) procedures; major procedure-related adverse events (AEs) in 2 (1.6%) patients; hepatic encephalopathy in 33 (26.2%) patients; portal hypertensive rebleeding in 26 (20.6%) patients; 98%, 81%, and 73% rebleeding free rates at 6 weeks, 1 year, and 3 years, respectively; and 98%, 66%, and 54% overall survival (OS) probability at 6 weeks, 1 year, and 3 years, respectively.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
